Cole Cheney, MD
Pain Medicine · Mankato, MNNPI 1922539568
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Medtronic at 48.8% of the total. Reporting peaked in 2023 at $1,680 and has fallen 98.6% since, to $23 in 2025.
Across 43 payments — averaging $88.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Relievant Medsystems, Inc.$1K
- Nevro Corp.$429
- Abbott$215
- Stimwave Technologies Incorporated$87
- Pacira Therapeutics, Inc.$39
- plus $23 from 1 others
What the payments were for
- Travel & lodging$2,13356%
- Food & beverage$1,68844%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 24 | $1,865 |
| Relievant Medsystems, Inc. | 7 | $1,163 |
| Nevro Corp. | 3 | $429 |
| Abbott | 2 | $215 |
| Stimwave Technologies Incorporated | 4 | $87 |
| Pacira Therapeutics, Inc. | 2 | $39 |
| Stryker | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,935
- INTELLIS ADAPTIVESTIM$1,083
- Omnia$429
- Proclaim DRG IPG$165
How this compares
$3,820 in reported general payments places this provider in the 60th percentile of 88 pain medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 17 | $1,759 |
| Gabapentin | 65 | $1,356 |
| Pregabalin | 25 | $595 |
| Oxycodone Hcl | 33 | $137 |
| Nortriptyline Hcl | 11 | $132 |
| Cyclobenzaprine Hcl | 12 | $114 |
| Tizanidine Hcl | 11 | $96 |
| Diazepam | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Mankato
- Richard StaynerEdina$105K
- David SchultzEdina$99K
- Jonathan HagedornRochester$83K
- Michael McEntireRochester$70K
- Ronald BoedingMaple Grove$68K
- Matthew ThorsonEdina$59K
- Sherri HaasEdina$51K
- Cody FosterCoon Rapids$36K
- Katelyn Parker-McgillAlexandria$32K
- Louis SaegerEdina$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.